Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein

Biochemical Journal

Volumn 357, Issue 1, 2001, Pages 289-296

  Andersen, O M ^a   Petersen, H H ^a   Jacobsen, C ^a   Moestrup, S K ^a   Etzerodt, M ^a   Andreasen, P A ^a   Thogersen H C ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Complement type repeat; Protein protein interactions; Receptor associated protein

Indexed keywords

BINDING ENERGY; CHEMICAL ACTIVATION; ENZYME INHIBITION; PROTEINS;

LIGANDS;

BIOCHEMISTRY;

LOW DENSITY LIPOPROTEIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE;

ANIMAL CELL; ARTICLE; BINDING SITE; CLUSTER ANALYSIS; COMPLEMENT ACTIVATION; COMPLEX FORMATION; ENDOCYTOSIS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITES; BINDING, COMPETITIVE; CALCIUM; COMPLEMENT SYSTEM PROTEINS; CONSERVED SEQUENCE; DISULFIDES; HUMANS; KINETICS; LDL-RECEPTOR RELATED PROTEIN 1; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 0035395799     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3570289     Document Type: Article

References (54)

1. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor
2. 2-macroglobulin receptor
3. Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor
4. Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity
5. Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA
6. Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain
7. Complete cloning and sequencing of rat gp330/'megalin', a distinctive member of the low density lipoprotein receptor gene family
8. 2+-binding receptor with potential intracellular signaling properties
9. 2-macroglobulin receptor-associated protein
10. Isolation and characterization of LRPC, a novel member of the low density lipoprotein receptor gene family
11. Cloning of a novel member of the low-density lipoprotein receptor family
12. A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E
13. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity
14. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands
15. The low-density lipoprotein receptor gene family: Multiple roles in lipid metabolism
16. Lipoprotein receptors: New roles for ancient proteins
17. Apolipoprotein E receptors: Linking brain development and Alzheimer's disease
18. 2-macroglobulin receptor and epithelial glycoprotein-330: Two giant receptors mediating endocytosis of multiple ligands
19. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor
20. 2-macroglobulin receptor
21. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation
22. 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes
23. An extracellular β-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components
24. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor
25. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids
26. 2-macroglobulin
27. NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein
28. Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor
29. Three-dimensional structure of the second cysteine-rich repeat from the human low-density lipoprotein receptor
30. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module
31. Solution structure of the sixth LDL-A module of the LDL receptor
32. The urokinase-type plasminogen activator system in cancer metastasis: A review
33. The plasminogen activation system in tumor growth, invasion, and metastasis
34. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex
35. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes
36. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes
37. 2-Macroglobulin receptor/LDL receptor-related protein (Lrp)-dependent internalization of the urokinase receptor
38. Recycling of the urokinase receptor upon internalization of the uPA·serpin complexes
39. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor
40. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase
41. 2-macroglobulin receptor containing a cluster of eight complement-type repeats
42. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding
43. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP
44. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells
45. 2-macroglobulin-receptor-associated protein
46. 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition
47. 2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor
48. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator
49. Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein
50. Folding, calcium binding, and structural characterization of a concatemer of the first and second ligand-binding modules of the low-density lipoprotein receptor
51. Structural independence of ligand-binding modules five and six of the LDL receptor
52. Specific binding of α-macroglobulin to complement-type repeat CR4 of the low density lipoprotein receptor-related protein
53. 2-macroglobulin receptor as an approximately 440-kDa single chain protein
54. MOLMOL: A program for display and analysis of macromolecular structures